Conference Coverage

Licia Grazzi, MD

Publish date: May 8, 2014

Licia Grazzi, MD, talks with Alan Rapoport, MD, about her open-label study of the noninvasive Gammacore device for the acute treatment of chronic migraine, the results of which were presented at the 66th Annual Meeting of the American Academy of Neurology.


 

Online-Only Materials

AttachmentSize
File Grazzi_qtp.mp476.77 MB

Recommended Reading

Shivang Joshi, MD, MPH, RPh
MDedge Neurology
Stewart Tepper, MD
MDedge Neurology
Randall Weeks, PhD
MDedge Neurology
Neurologists and Patient Groups Seek More Funds for Headache Research
MDedge Neurology
Routine Neuroimaging for Headache Is Increasing Despite Guidelines’ Recommendations
MDedge Neurology
Concussion—A Public Health Crisis
MDedge Neurology
Are Cannabinoids and Hallucinogens Viable Treatment Options for Headache Relief?
MDedge Neurology
Does Drug Labeling Affect Treatment Outcome?
MDedge Neurology
Experimental Agent Boosts Hope for Monoclonal Antibody Treatment of Migraine
MDedge Neurology
Michael Wall, MD
MDedge Neurology